Hims & Hers Health, Inc. - 8-K Summary
Business Context and Reporting Period
This Form 8-K reports the results of the Annual Meeting of Stockholders held on June 11, 2026. The filing details the voting outcomes for three proposals presented to shareholders of record as of April 15, 2026.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting results.
Material Changes and Voting Results
Stockholders voted on three proposals. The Company has a dual-class share structure where Class V shares carry 175 votes per share, while Class A shares carry one vote per share. Total outstanding shares entitled to vote were 222,525,754 Class A and 8,377,623 Class V.
- Proposal 1 (Election of Directors): All nine nominees were elected. Votes ranged from approximately 1.50 billion to 1.52 billion "For" votes. Broker non-votes totaled 74,228,233 for all nominees.
- Proposal 2 (Ratification of Auditors): KPMG LLP was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2026. The vote was 1,591,246,881 "For" versus 516,386 "Against".
- Proposal 3 (Executive Compensation): The advisory approval of executive compensation passed with 1,506,477,171 "For" votes and 11,181,420 "Against" votes.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management commentary on financial outlook, specific risks, contingencies, or unusual items. The document serves solely to disclose the tabulation of stockholder votes.
Key Facts for Investor Verification
- Verify the definitive proxy statement (Schedule 14A) filed on April 28, 2026, for detailed biographies of the elected directors and the specific executive compensation plan approved.
- Confirm the impact of the dual-class voting structure (175:1 ratio for Class V shares) on the final vote totals.
- Note that KPMG LLP is confirmed as the auditor for the fiscal year ending December 31, 2026.
- Review the "Withheld" votes for directors Andrew Dudum and David Wells, which were higher than other nominees (13 million and 16 million respectively), to assess potential shareholder sentiment regarding specific board members.